These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28168962)

  • 1. Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support.
    Yoshioka D; Takayama H; Colombo PC; Yuzefpolskaya M; Garan AR; Topkara VK; Han J; Kurlansky P; Naka Y; Takeda K
    Ann Thorac Surg; 2017 Mar; 103(3):717-724. PubMed ID: 28168962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device.
    Deo SV; Sharma V; Altarabsheh SE; Hasin T; Dillon J; Shah IK; Durham LA; Stulak JM; Daly RC; Joyce LD; Park SJ
    Heart Lung Circ; 2014 Mar; 23(3):229-33. PubMed ID: 23992754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
    Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Topkara VK; Coromilas EJ; Garan AR; Li RC; Castagna F; Jennings DL; Yuzefpolskaya M; Takeda K; Takayama H; Sladen RN; Mancini DM; Naka Y; Radhakrishnan J; Colombo PC
    Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27932533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Colombo PC; Yuzefpolskaya M; Fukuhara S; Han J; Kurlansky P; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Aug; 34(8):1024-32. PubMed ID: 25935438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset right ventricular dysfunction after mechanical support by a continuous-flow left ventricular assist device.
    Kapelios CJ; Charitos C; Kaldara E; Malliaras K; Nana E; Pantsios C; Repasos E; Tsamatsoulis M; Toumanidis S; Nanas JN
    J Heart Lung Transplant; 2015 Dec; 34(12):1604-10. PubMed ID: 26163154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.